LM
VNRX icon

Luminus Management’s VolitionRx Ltd VNRX Stock Holding History

Luminus Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201K Buy
+49,750
New +$238K 0.12% 24

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Luminus Management's VNRX Position: Q1 2026 in Review

Luminus Management opened a new position in VolitionRx Ltd (VNRX) in Q1 2026: 49,750 shares worth $201K. The stake represents 0.12% of the portfolio and ranks #24 among its holdings.

31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Luminus Management held 49,750 shares of VolitionRx Ltd worth $201K as of Q1 2026.
  • VolitionRx Ltd was a new Luminus Management position in Q1 2026.
  • VolitionRx Ltd made up 0.12% of Luminus Management's portfolio in Q1 2026, its #24 holding.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Luminus Management's 13F filing for Q1 2026, filed 15 May 2026.